2 Marzo
- Stand
- 2 Marzo
- 3 Marzo
- 4 Marzo
- 5 Marzo
ACCIÓN en AZ Booth
Chronity
Ganadores ACCIÓN
Hall 8.0 – 4YFN & Partner District Stand 8.0B11.4
App que combina seguimiento de síntomas, red social e investigación para enfermedades crónicas.
Jose Luis Madrona González
All day
Sycai Medical
Ganadores ACCIÓN
Hall 8.0 – 4YFN & Partner District Stand 8.0B11.4
IA en imagen médica para detectar y monitorizar lesiones hepáticas de forma precoz e integrarse en sistemas hospitalarios.
Sara Toledano Sáez
All day
Demo Space AZ Booth
Beyond Molecules: How emerging technologies translate to patient impact
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Keynote
How AstraZeneca Turns Emerging Technologies Into Patient Impact
Marta Arenas - Associate Director, Digital Services, Emerging Technology Intelligence, AstraZeneca
15:00h - 15:30h
Quantum Technology
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Keynote
Quantum Technologies
Jordi Mur - Associate Director, Digital Services, Emerging Technology Intelligence, AstraZeneca
15:30h - 16:00h
3 Marzo
ACCIÓN en AZ Booth
MiMiat Health
Ganadores ACCIÓN
Hall 8.0 – 4YFN & Partner District Stand 8.0B11.4
Infraestructura de datos anclada en el paciente crónico con pasaporte de salud digital y RWD compartido en tiempo real.
Suraj Rajesh
All day
Synthetrial
Ganadores ACCIÓN
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.4
Generación de datos sintéticos con IA para optimizar ensayos clínicos y datasets de pacientes.
Jose Ignacio Klett Mingo
All day
Demo Space AZ Booth
From trajectories to phenotypes: Advanced RWD analytics for hypertension stratification
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Demo
RWD analytics for hypertension stratification
Alexia Giannoula - Associate Director, Real World Data Science, AstraZeneca R&D
11:00h - 11:30h
MG Connect: One Global App Built to Scale for MG Patients Locally
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Demo
A mobile app that enables and empowers gMG patients to track their MG symptoms using MG‑ADL scales on a regular basis and share reports with their HCPs
Sofia Foutsitzis - Director IT Business Partner, AstraZeneca RDU Anabel Leon - Associate Director IT Business Partner, AstraZeneca RDU
14:30h - 15:00h
Consortium Collaboration: Preciseu
Roundtable
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Montse Daban, Director Strategic Foresight and International Relations,-Biocat Miquel A. Bru , Cofounder & CBDO- Genomcore Simón de Miquel Ribas, Strategic Project Manager at the Advanced Therapies Platform- Hospital San Joan de Déu Mireia Monràs, Scientific Management Area & Marta Rotxés, Clinical trial study coordinator-Vall d’Hebron Institute of Oncology Eider Del Hoyo Lasa, Co-founder Biocare - PediAItrics
15:00h - 15:30h
Responsible AI in R&D and deep tech healthcare
Roundtable
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Montse Daban, Director Strategic Foresight and International Relations,-Biocat Miquel A. Bru , Cofounder & CBDO- Genomcore Simón de Miquel Ribas, Strategic Project Manager at the Advanced Therapies Platform- Hospital San Joan de Déu Mireia Monràs, Scientific Management Area & Marta Rotxés, Clinical trial study coordinator-Vall d’Hebron Institute of Oncology Eider Del Hoyo Lasa, Co-founder Biocare - PediAItrics
15:30h - 16:00h
Virtual Human Twins for Rare Disease Clinical Development
Demo
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Diego Arguello - Director Clinical Development Scientist, AstraZeneca Mariano Vázquez - Co-founder, ELEM Biotech Alberto Zingaro - PhD Senior Scnientist, ELEM Biotech
16:00h - 17:00h
4 Marzo
ACCIÓN en AZ Booth
Diabyuda
Ganadores ACCIÓN
Hall 8.0 – 4YFN & Partner District Stand 8.0B11.4
Personaliza el tratamiento de diabetes integrando guías clínicas para optimizar decisiones terapéuticas y mejorar resultados en salud.
Joaquín de Carlos Artajo
All day
Corsonic
Ganadores ACCIÓN
Hall 8.0 – 4YFN & Partner District Stand 8.0B11.4
Índice Acústico™ con IA para analizar ecocardiogramas en tiempo real y apoyar diagnósticos más precisos.
Matías Pérez Paredes
All day
Amadix
Ganadores ACCIÓN
Hall 8.0 – 4YFN & Partner District Stand 8.0B11.4
DiagnoLung integra biomarcadores en sangre, imagen y factores de riesgo con IA para evaluar malignidad en nódulos pulmonares.
Maria Elena Sánchez Viñes
All day
Demo Space AZ Booth
Leveraging operational data to optimize clinical trial efficiency and accelerate drug development
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Keynote
Leveraging operational data to optimize clinical trial efficiency and accelerate drug development
Laura Lesauvage - Operational Data Strategy, AstraZeneca R&D Janet Girona - Operational Data Strategy, AstraZeneca R&D Maria Cortes - Operational Data Strategy, AstraZeneca R&D
10:30h - 11:00h
Presenting projects from BSC: Krebstein, RapidAIM, Stratum, miCRC, Onecare.AI
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Pitch
Project pitches in collaboration with Barcelona Supercomputing Center
Alberto Rodriguez - Innovation Business Developer, BSC Davide Cirillo - ML Lead investigator, BSC Uma Lal Trehan Estrada - Research engineer, BSC Paula Petrone - Research Lead, BSC Asaf Badouh - Research engineer, BSC Toni Gabaldon - Research Lead, BSC Daniele Lezzi - Senior Resercher, BSC
11:00h - 12:00h
Rare Tech, Real Impact: Innovation that improves lives of patients with rare diseases
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Keynote
Innovacion en enfermedades Raras
Ana Richart - Senior Manager Corporate Brand & Creative, AstraZeneca RDU Antonio Quesada - Digital Lead, AstraZeneca RDU
12:00h - 12:30h
Ganadores Accion: Profesionales sanitarios
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Pitch
Ganadores Acción: Categoría Profesional Sanitario 1- PIERCIA, un CDSS que convierte guías clínicas en decisiones automáticas y personalizadas según el riesgo cardio-reno-metabólico del paciente. 2- Gemelos digitales y datos sintéticos para la predicción temprana de exacerbaciones en asma grave 3 - Solución que monitoriza la progresión de GMSI a partir de analíticas rutinarias, ajustando el seguimiento de forma dinámica y anticipada. 4- EPORisk, solución de IA que identifica y estratifica riesgo cardiovascular oculto en pacientes con EPOC a partir de TACs torácicos ya disponibles."
Dr. José Escribano Serrano - Área de Gestión Sanitaria Campo de Gibraltar Este Dra. Asunción Nieto Barbero - Hospital Clínico San Carlos Dra. Amparo Santamaría - Hospital Universitario de Vinalopó [ONLINE] Dr. Miguel Jiménez Gómez - Hospital 12 de Octubre
12:30h - 14:00h
5 Marzo
ACCIÓN en AZ Booth
MiMiat Health
Demo
Hall 8.0 – 4YFN & Partner District Stand 8.0B11.4
Suraj Rajesh
All day
Medsys AI
Demo
Hall 8.0 – 4YFN & Partner District Stand 8.0B11.4
Vigilancia proactiva con triangulación de biomarcadores digitales, información del entorno y datos del paciente.
Manuel Pinilla Martín
All day
Demo Space AZ Booth
Human‑Centered, AI‑Powered: The Strategic Evolution of Medical Learning in rare diseases
Pitch
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Ariadna Laporte - Global Medical Learning Partner, AstraZeneca RDU Eva Vila - Global Medical Learning Partner, AstraZeneca RDU Bruna de Vita - Global Medical Learning Partner, AstraZeneca RDU David Lopez - Global Training and Capabilities Partner, AstraZeneca RDU
10:30h - 11:30h
Scaling Patient Understanding with AI Video—Enhancing Education and Interest in V&I Clinical Trials
Demo
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Fernanda Andrade - Global Development Medical Director, AstraZeneca R&D
11:30h - 12:00h
DIALOGUE—An AI Assistant for Faster, Trusted Clinical Trial Data Queries and Visualization
Demo
Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.2
Fernanda Andrade - Global Development Medical Director, AstraZeneca R&D
12:00h - 12:30h
Talent Arena Official Program
Beyond Agentic AI: Designing the Future of Healthcare with Women in STEM
Plug-in Talks
At AstraZeneca, science, data and technology drive AI-enabled healthcare. We’re advancing from generative AI (faster thinking/learning) to agentic AI (acting across complex systems) across discovery, development, evidence and patient care. The Hub blends scientific rigor, digital expertise and responsible AI, builds the future workforce,especially women in STEM, and offers frontier opportunities, non-linear careers and purpose-led impact.
Moderador: Cesar Velasco, MD, PhD. Enterprise Innovation Madrid & Barcelona Director at AstraZeneca Participantes: Cecilia Girón, Director of Data Science at Evinova; Elena Millán, Director, RDU IT – Product Management, Knowledge Management, and AI Content Supply Chain at Alexion, Marta Tolos, Executive Director, Enterprise AI Platforms & Services at AstraZeneca
11:30h - 12:30h
MWC Official Programme
A New Era of Care: AstraZeneca's AI Shaping Healthcare's Next Frontier
Keynote Lamarr Stage, Hall 6
Digital Health Summit: Powering the Future of Healthcare Through Connectivity @ Lamarr Stage
Marta Tolos, Executive Director, Enterprise AI Platforms & Services at AstraZeneca
15:00h - 18:00h CET Doors Open 14:40h
Powering the Patient Journey: How pharma, tech and connectivity are redesigning care
Session Panelist Lamarr Stage, Hall 6
Digital Health Summit: Powering the Future of Healthcare Through Connectivity @ Lamarr Stage
Cesar Velasco, MD, PhD. Enterprise Innovation Madrid & Barcelona Director at AstraZeneca
15:00h - 18:00h CET Doors Open 14:40h
4YFN Official Programme
Hope, Proven: Voice AI Follow‑Up So No Patient Falls Through the Cracks
Banco Sabadell Stage, Hall 8.0
Hope, Proven: Voice AI Follow‑Up So No Patient Falls Through the Cracks” brings a pharma, a founder, and a frontline nurse to show how voice AI moves from pilot to everyday care. We’ll trace a real workflow—from automated symptom check‑ins to clinician action—and share measurable outcomes such as higher reach and engagement, earlier interventions, reduced readmissions or ER visits, and capacity freed for HCPs. The discussion will spotlight guardrails (human‑in‑the‑loop oversight, privacy, bias checks) and the evidence that differentiates hope from hype, closing with a practical checklist organizations can use to scale responsibly.
Moderador: Madeleine Thun, Senior Director, Alliances and Strategic Partnerships Participantes: María González, CEO & Co-Founder TUCUVI; Merce Faraudo, Consorci Sanitari Integral Heart Failure Nurse
12:20h - 12:50h
Miracle Cure or Placebo? AI’s Current Impact on Healthcare
Agora Stage, Hall 8.0
This keynote invites the industry to confront that question head-on. From pharma labs using AI to accelerate clinical trials, to hospitals deploying AI in diagnostics and workflows, to insurers and startups experimenting with predictive analytics and virtual care - where is AI genuinely improving outcomes, and where is it still stuck in pilot mode?
Jacky Abitbol, Partner, Cathay Innovation Jorge Juan Fernández Garcia, Chief Innovation Officer, Hospital Clinic Barcelona Malbinder Fagura, Global Transform Care Director, AstraZeneca Carmen Pauline Rios Benton, CEO & Founder, Dotomatic Moderator: Yolanda Puiggros Jimenez, PWC Partner
15:00h - 16:00h
Talent Arena Official Program
The Future of Enterprise AI Governance
Visionary Stage
Keynote
AI is now democratized, reshaping every role and organization. As it becomes embedded in work, how do we keep it trustworthy, compliant, and safe? Enterprise AI Governance is critical, yet most organizations are just beginning. Oliver Patel, who leads AI governance at AstraZeneca and authored Fundamentals of AI Governance, shares how regulations are evolving, why AI literacy is essential, and how agentic AI changes the game.
Speaker: Oliver Patel, Head of Enterprise Artificial Intelligence Governance at AstraZeneca
12:00h - 12:30h
AstraZeneca Sky Stage
Opening Keynote: The Power of Artificial Intelligence in a Global Health Hub
Hall 8.0 – 4YFN & Partner Theatres
Keynote
Opening keynote setting the strategic context for the day, outlining AstraZeneca’s global innovation vision and the role of digital technologies, AI and data-driven science in reshaping healthcare, R&D and patient outcomes.
David Dellamonica, VP Head of AI to Transform Care
10:00h - 10:15h
Engineering Rare Disease Care: Virtual Human Twins and Augmented Reality
Hall 8.0 – 4YFN & Partner Theatres
Roundtable
Expert roundtable exploring how digital twin technologies are being applied in rare diseases to accelerate clinical development, simulate disease progression, optimise trial design and improve decision‑making in high–unmet‑need areas.
Moderator: Ricardo Damas. VP and General Manager Alexion Iberia Participants: Antonio Quesada, Digital Lead Alexion Iberia; Diego Argüello, Director Clinical Development Scientist Alexion Pharmaceuticals
10:15h - 10:45h
From Algorithms to Impact: How Artificial Intelligence Is Transforming Care at Scale
Hall 8.0 – 4YFN & Partner Theatres
Roundtable
This session examines how AI solutions move beyond pilots to deliver measurable impact at scale.
Moderator: Christophe Dufour. Global Head of Digital Precision Healthcare at AstraZeneca Participants: Martina Furegato. Principal / Senior Manager – RWE at Oracle Life Sciences; Meriem Sefta. Chief Diagnostic Officer at Owkin Dx ; Raul Herance. MD, Head of the Medical Molecular Imaging Research Group at Vall d’Hebron Research Institute"
10:45h - 11:15h
AstraZeneca Global Hub in Barcelona: How Tech Is Transforming Care
Hall 8.0 – 4YFN & Partner Theatres
Roundtable
Discussion on how digital tools, data platforms, and emerging technologies are reshaping care pathways and enabling more proactive, efficient, and patient‑centred healthcare models.
Moderator: Marta Tolos. Executive Director Enterprise AI Platforms at AstraZeneca Panelists: Mario Sänger. Associate Principal AI Engineer at AstraZeneca; Madalina Ciortan. Director AI OpsIT at AstraZeneca; Michael Crandford. Director Commercial IT Data & AI Capabilities at AstraZeneca; Panagiotis Sereleas. Director RDU IT Data Science at AstraZeneca; Albert Maristany. Product Lead BIKG R&D IT at AstraZeneca
11:15h - 11:45h
Smarter Trials for a Healthier Future
Hall 8.0 – 4YFN & Partner Theatres
Keynote
Forward‑looking roundtable on the evolution of clinical trials, transforming how evidence is generated and accelerating access to innovation.
Moderator: César Velasco. MD, PhD. Enterprise Innovation Director Madrid & Barcelona Panelists: Mercedes Luz. PhD. Sr. Director, Cluster Head Biopharmaceuticals Site Management & Monitoring; Emiliano Calvo, MD, PhD. Director Europa START Madrid -CIOCC Unit, Early Phase clinical trials; Antonio L. Andreu, MD, PhD. Scientific Director EATRIS
12:00h - 12:30h
The Last Mile of Artificial Intelligence: From Global to Local
Hall 8.0 – 4YFN & Partner Theatres
Roundtable
A practical discussion on the challenges of deploying global AI strategies within our bio‑region, drawing on the learnings and capabilities of the A.Catalyst Network, a global network of innovation hubs.
Moderator: Madeleine Thun, Senior Director A.Catalyst Network AstraZeneca Panelists: Miguel Lancha, Enterprise Innovation Lead & Global Transform Care Director; Gwen Jacquand, Digital, Health & Innovation Director; David Coelingh Bennink, Head of Policy
12:30h - 13:00h
Opening: Leading the Transformation of the Healthcare System through AstraZeneca’s Spanish Healthcare Innovation Hub
Hall 8.0 – 4YFN & Partner Theatres
Keynote
Bienvenida institucional por parte de AstraZeneca España, destacando el compromiso de la compañía con la transformación del sistema sanitario en España.
Speaker: Laura Colón. President of AstraZeneca Spain and Site Leader of the AstraZeneca Global Hub in Barcelona
14:30h - 14:40h
Restricted access by invitation only. Acceso restringido solo con invitación
Human in the Loop: The Next Frontier of Health Innovation
Hall 8.0 – 4YFN & Partner Theatres
Keynote
Sesión centrada en el papel fundamental de los profesionales sanitarios, los pacientes y los actores del ecosistema sanitario en la innovación impulsada por la inteligencia artificial.
Moderador: Dra. Katherin Martínez-Barroso, MBA. Enterprise Innovation Manager en AstraZeneca Participantes: Dr. Joaquín Rodríguez. PhD, MBA.. Especialista en Aparato Digestivo. Jefe de servicio digestivo Quirón Salud CLM. Divulgador de IA Ignacio Sarasúa, PhD, MBA. Solution Architect at NVIDIA, Digital Health
14:40h - 15:00h
Restricted access by invitation only. Acceso restringido solo con invitación
AI‑Powered Oncology: From Promise to Clinical Impact Innovation
Hall 8.0 – 4YFN & Partner Theatres
Panel
Tres estudios clínicos en distintas fases de desarrollo muestran cómo la inteligencia artificial puede aplicarse al diagnóstico precoz, la detección de efectos adversos y el análisis de imagen en oncología. Un debate honesto sobre evidencia, retos y el verdadero impacto de la IA en la práctica clínica.
Moderador: Dra. Ana Peiró. Head of Oncology AstraZeneca Participantes: Dra. Regina García Delgado, Hematóloga en Hospital Universitario Virgen de la Victoria Málaga & Investigadora responsable del Grupo BE21: Hematología e Inmunoterapia, IBIMA Plataforma BIONAND. Dr. Alfonso Cortés Salgado, Oncólogo Médico (Sección de tumores de mama y ginecológicos) en Hospital Universitario Ramón y Cajal Madrid; Dr. Luis Gorospe-Sarasúa, Radiólogo torácico en Hospital Universitario Ramón y Cajal Madrid.
15:00h - 15:30h
Restricted access by invitation only. Acceso restringido solo con invitación
From Data to Clinical Action in Cardiovascular, Renal, and Metabolic CareInnovation
Hall 8.0 – 4YFN & Partner Theatres
Panel
Presentación de distintos casos de herramientas de apoyo a la toma de decisiones clínicas y cómo mejoran los circuitos asistenciales para pacientes con patologías CVRM.
Moderador: Ilmo. Sr. D. Bernardo Valdivieso. Secretario autonómico de Planificación, Información y Transformación Digital en la Conselleria de Sanidad de la Generalitat Valènciana. Participantes: Dr. Enrique Rodríguez, Jefe de Servicio del Laboratorio de Bioquímica Clínica y Patología Molecular del Hospital Clínico de Valencia ;Dr. Emilio Flores, Jefe de Servicio del Laboratorio Clínico del Hospital del Hospital de San Juan de Alicante; Dra. Maribel Troya Saborido, Servicio Nefrologia, Hospital Universitari Germans Trias i Pujol, Badalona
15:30h - 16:00h
Restricted access by invitation only. Acceso restringido solo con invitación
Detecting Signals, Transforming Decisions in the Clinical Setting - Artificial Intelligence and Amyloidosis Innovation
Hall 8.0 – 4YFN & Partner Theatres
Panel
Cómo las herramientas basadas en inteligencia artificial están permitiendo una detección más temprana de la amiloidosis por transtiretina (ATTR), mejorando los circuitos diagnósticos y apoyando a los profesionales sanitarios en procesos de toma de decisiones complejas.
Moderador: Miguel Lancha Luquero. Entreprise Innovation Lead Participantes: Dr. Manuel Marina Breysse. CEO, cardiólogo y cofundador de IDOVEN. Dra. Esther González López. Médico adjunto e investigadora clínica. Unidad de Cardiopatías Familiares. Hospital Universitario Puerta de Hierro; Christine Gouillard. Responsable de Alianzas y enlace médico en Us2.ai.; Dr. Albert Teis Soley. Adjunto del Servicio de Cardiología. Departamento de Imagen Cardiovascular. Institut del Cor. Hospital Germans Trias i Pujol.
16:30h - 17:00h
Restricted access by invitation only. Acceso restringido solo con invitación
From Reactive to Proactive Care: AI‑Driven Early Intervention for Chronic Patients Innovation
Hall 8.0 – 4YFN & Partner Theatres
Panel
Casos reales sobre cómo la integración de inteligencia artificial y datos clínicos está permitiendo una detección más temprana del riesgo en enfermedades crónicas, con el lupus, asma grave y EPOC
Moderador: Jorge del Estal, Unidad de Farmacia Ambulatoria Hospital Universitario Parc Tauli Participantes: Dr. Javier Bachiller, Jefe de Sección Reumatología en Hospital Universitario Ramón y Cajal; Isaac Cano. CEO HealthCircuit; Dra. Ebymar Arismendi, Coordinadora Unidad Asma Grave en Hospital Clinic; Dr. Carlos Egea, Jefe de Servicio Neumología Hospital Universitario Araba; Dr. José Manuel Calleja, Médico especialista en Medicina de Familia y Comunitaria en Osakidetza
17:00h - 17:40h
Restricted access by invitation only. Acceso restringido solo con invitación
Physicians and AI: Collaborating for Better Patient Care. From Reactive to Proactive Care: AI‑Driven Early Intervention for Chronic Patients Innovation
Hall 8.0 – 4YFN & Partner Theatres
Roundtable
Esta ponencia explora cómo médicos y tecnología pueden colaborar para mejorar la atención, abordando oportunidades, desafíos de adopción y claves para una integración segura y efectiva en la práctica clínica.
Moderador: Dr. Diego Benavent, Reumatólogo. Hospital Universitari de Bellvitge. Participantes: Mar Pujadas, Co-Founder & CEO at Omniloy; Daniel Heinisch. Co-Founder & CEO at Recog Analytics
17:40h - 18:00h
Restricted access by invitation only. Acceso restringido solo con invitación
Cierre institucional
Hall 8.0 – 4YFN & Partner Theatres
Javier Selva. DG de Transferència i Societat del Coneixement de la Generalitat de Catalunya.
18:00h
MWC Official Programme
Built-In, Not Bolt-On: Co-Designing for Inclusive Consumer Experiences
Session Speakers Marconi Stage, Hall 6
Patient Monitoring Devices @ Turing Stage
Laura Dubreuil, Director, Emerging Technology Intelligence Research
12:30h - 13:15h
.
La información que figura en www.azone.es está dirigida exclusivamente al profesional facultado para prescribir, dispensar o indicar medicamentos por lo que se requiere una formación especializada para su correcta interpretación. Por favor no distribuir en medios, soportes o canales de comunicación dirigidos a público general. Para la notificación de reacciones adversas puede dirigirse a la dirección de AstraZeneca www.contactazmedical.astrazeneca.com
© 2025 AstraZeneca One
Soporte válido nº: Nº 6/23- W– CM - ES-25956 Diciembre 2023